Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma

International Journal of Dermatology

Volumn 48, Issue 7, 2009, Pages 763-767

  Nakamura, Yoshiyuki ^a   Nakamura, Yasuhiro ^a   Hori, Enmi ^a   Furuta, Junichi ^a   Ishii, Yoshiyuki ^a   Takahashi, Takenori ^a   Kawachi, Yasuhiro ^a   Otsuka, Fujio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CISPLATIN; CYSTEINYLDOPA; DACARBAZINE; DIURETIC AGENT; GAMMA GLUTAMYLTRANSFERASE;

ACUTE KIDNEY FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CHOROID MELANOMA; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; ECHOGRAPHY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERURICEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LIVER FAILURE; LIVER METASTASIS; MALAISE; MALE; MUSCLE WEAKNESS; NAUSEA; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PROTON THERAPY; REHYDRATION; SIDE EFFECT; TUMOR LYSIS SYNDROME; UPPER ABDOMINAL PAIN; URIC ACID BLOOD LEVEL;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TUMOR LYSIS SYNDROME;

EID: 67649225072     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04087.x     Document Type: Article

References (34)

1. Lorigan PC, Woodings PL, Morgenstern GR, et al. Tumour lysis syndrome, case report and review of the literature. Ann Oncol 1996; 7: 631-636.
2. Altman A. Acute tumor lysis syndrome. Semin Oncol 2001; 28: 3-8.
3. Jeha S. Tumor lysis syndrome. Semin Hematol 2001; 38: 4-8.
4. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000; 27: 322-334.
5. Lehner SG, Gould JE, Saad WE, et al. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. Am J Roentgenol 2005; 185: 1307-1309.
6. Annemans L, Moeremans K, Lamotte M, et al. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma 2003; 44: 77-83.
7. Baeksgaard L, Sorensen JB. Acute tumor lysis syndrome in solid tumors - a case report and review of the literature. Cancer Chemother Pharmacol 2003; 51: 187-192.
8. Vaisban E, Braester A, Mosenzon O, et al. Spontaneous tumor lysis syndrome in solid tumors: Really a rare condition? Am J Med Sci 2003; 325: 38-40.
9. Lin CJ, Lim KH, Cheng YC, et al. Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma. Med Oncol 2007; 24: 455-457.
10. Lin CJ, Hsieh RK, Lim KH, et al. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer. South Med J 2007; 100: 916-917.
11. Saylor PJ, Reid TR. Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib. J Clin Oncol 2007; 25: 3544-3546.
12. Nicholaou T, Wong R, Davis ID. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate. Lancet 2007; 369: 1923-1924.
13. Theodorou D, Lagoudianakis E, Pattas M, et al. Pretreatment tumor lysis syndrome associated with bulky retroperitoneal tumors. Recognition is the mainstay of therapy. Tumori 2006; 92: 540-541.
14. Sakamoto N, Monzawa S, Nagano H, et al. Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma. Cardiovasc Intervent Radiol 2007; 30: 508-511.
15. Kawai K, Takaoka E, Naoi M, et al. A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome. Jpn J Clin Oncol 2006; 36: 665-667.
16. Ajzensztejn D, Hegde VS, Lee SM. Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer. J Clin Oncol 2006; 24: 2389-2391.
17. Lee CC, Wu YH, Chung SH, et al. Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma. Oncologist 2006; 11: 87-88; author reply 9.
18. Wright JL, Lin DW, Dewan P, et al. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer. Int J Urol 2005; 12: 1012-1013.
19. El Mesbahi O, Beaudoin A, Louvet C, et al. [Tumor lysis syndrome after chemotherapy for colon small cell carcinoma]. Rev Med Interne 2004; 25: 768-769.
20. Sorscher SM. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Cancer Chemother Pharmacol 2004; 54: 191-192.
21. Busam KJ, Wolchok J, Jungbluth AA, et al. Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma. J Cutan Pathol 2004; 31: 274-280.
22. Trobaugh-Lotrario AD, Liang X, Janik JS, et al. Difficult diagnostic and therapeutic cases: CASE 2. thymoma and tumor lysis syndrome in an adolescent. J Clin Oncol 2004; 22: 955-957.
23. Sewani HH, Rabatin JT. Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor. Mayo Clin Proc 2002; 77: 722-728.
24. Chan JK, Lin SS, McMeekin DS, et al. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. J Clin Oncol 2005; 23: 6794-6795.
25. Kurt M, Onal IK, Elkiran T, et al. Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma. Med Oncol 2005; 22: 203-206.
26. Oztop I, Demirkan B, Yaren A, et al. Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan. Tumori 2004; 90: 514-516.
27. Kushner BH, LaQuaglia MP, Modak S, et al. Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification. Med Pediatr Oncol 2003; 41: 80-82.
28. 3 ganglioside monoclonal antibody in patients with metastatic melanoma. Blood 1994; 83: 56-64.
29. Castro MP, VanAuken J, Spencer-Cisek P, et al. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature. Cancer 1999; 85: 1055-1059.
30. Stoves J, Richardson D, Patel H. Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy. Nephrol Dial Transplant 2001; 16: 188-189.
31. Habib GS, Saliba WR. Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: A case report and review of the literature. Am J Med Sci 2002; 323: 155-157.
32. Gemici C. Tumour lysis syndrome in solid tumours. Clin Oncol (R Coll Radiol) 2006; 18: 773-780.
33. Ponticelli C. Oncology and the Kidney, Vol. 3. Oxford: Oxford Medical Publications, 1998.
34. Wadei HM, Mai ML, Ahsan N, et al. Hepatorenal syndrome: Pathophysiology and management. Clin J Am Soc Nephrol 2006; 1: 1066-1079.